Drug Maker Krka 207th R&D Investor in EU

Brussels, 18 October - Investing EUR 90.92m in research and development in 2010, Slovenian drug maker Krka took 207th place on the list of 1,000 biggest R&D investors in the EU, according to a report of the European Commission presented on Tuesday. Krka's investment in R&D increased by EUR 2.6m in 2010 compared to the year before.